Suture of the Ovary After Enucleation of Ovarian Endometrioma

NCT ID: NCT03788720

Last Updated: 2021-04-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-05-31

Study Completion Date

2027-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Endometriosis is an estrogen-dependent chronic disease, characterized by the presence of ectopic endometrial-like tissue outside the uterine cavity.

According to the most updated guidelines of the European Society of Human Reproduction and Embryology (ESHRE), infertile women with endometriomas smaller than 3 cm should be addressed directly to Assisted Reproduction Technology (ART); conversely, for infertile women with endometriomas larger than 3 cm, enucleation of ovarian endometriomas could be considered in order to improve reproductive outcomes (both spontaneous and ART pregnancy rate).

To date, literature data do not allow to draw a firm conclusion about the best strategy to reduce ovarian damage during enucleation of ovarian endometriomas: in particular, investigators still lack robust evidence in order to choose between suturing the ovary or not after the enucleation.

In this scenario, the aim of our the study will be to compare functional outcomes of the ovary in a group of women undergoing suturing of the ovarian cortex after laparoscopic enucleation of endometriomas (cases) and a group of women undergoing laparoscopic enucleation of endometriomas without subsequent suture of the ovarian cortex.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Endometrioma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized Controlled Trial
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors
Surgeons who perform the surgery will be not masked for the treatment allocation.

Evaluators (sonographers, data analyzers) will be blind for the treatment allocation.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Suture

Women undergoing suturing of the ovarian cortex after laparoscopic enucleation of endometriomas.

Group Type EXPERIMENTAL

Suture of the ovarian cortex

Intervention Type PROCEDURE

Suture of the ovarian cortex after laparoscopic enucleation of endometriomas, using one single monofilament suture material, continuous suture technique with maximum 5 transfixion of the ovarian cortex and intracorporeal knots only (no extracorporeal knots).

No suture

Women undergoing laparoscopic enucleation of endometriomas without subsequent suture of the ovarian cortex.

Group Type SHAM_COMPARATOR

No suture of the ovarian cortex

Intervention Type PROCEDURE

Laparoscopic enucleation of endometriomas without suture of the ovarian cortex

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Suture of the ovarian cortex

Suture of the ovarian cortex after laparoscopic enucleation of endometriomas, using one single monofilament suture material, continuous suture technique with maximum 5 transfixion of the ovarian cortex and intracorporeal knots only (no extracorporeal knots).

Intervention Type PROCEDURE

No suture of the ovarian cortex

Laparoscopic enucleation of endometriomas without suture of the ovarian cortex

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women affected by one primary (no recurrent) monolateral ovarian endometrioma, with maximum diameter between 5 and 10 cm, undergoing laparoscopic enucleation by stripping technique;
* Normal AFC at the enrollment (baseline).

Exclusion Criteria

* Any other disease;
* Bilateral endometriomas;
* Deep infiltrating endometriosis;
* No previous pelvic surgery (even not gynecological);
* Any other pharmacologic and non pharmacologic treatment in the previous 3 months (wash-out period);
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Università degli Studi dell'Insubria

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Antonio Simone Laganà

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Antonio Simone Laganà, M.D.

Role: PRINCIPAL_INVESTIGATOR

Università degli Studi dell'Insubria

Fabio Ghezzi, M.D.

Role: STUDY_DIRECTOR

Università degli Studi dell'Insubria

Jvan Casarin, M.D.

Role: PRINCIPAL_INVESTIGATOR

Università degli Studi dell'Insubria

Simone Garzon

Role: PRINCIPAL_INVESTIGATOR

Università degli Studi dell'Insubria

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

"Filippo Del Ponte" Hospital

Varese, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Antonio Simone Laganà, M.D.

Role: CONTACT

+393296279579

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Antonio Simone Laganà, M.D.

Role: primary

+393296279579

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SOAVE-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Ethanol Sclerotherapy Prior to ART
NCT05962775 RECRUITING NA